Nursing and Lab partnering to perform

Slides:



Advertisements
Similar presentations
CAP/POCT 2003 Carol Riley-Hunte, RRT Senior Education Specialist Bayer HealthCare.
Advertisements

© Alere. All rights reserved. Proprietary & confidential. | 1 Performance and Results Interpretation iScreen ® OFD Cotinine Screen.
When You Need Results…Now! accutest ® ACCUTEST 5 - Drug Test Cup (Urine)
Module 14: Blood Collection and Handling Dried Blood Spot
The Joint Commission Chapter update: Waived Testing
Successful Solutions Professional Development LLC Chapter 3 Medication Management.
Grade “A” Laboratory Evaluation Program Ronald G. Brown Dairy Product Specialist/Laboratory Evaluation Officer NYS Department of Agriculture and Markets.
Clinical Laboratory Improvement Amendments of 1988 ( CLIA ’ 88 )
A Quality Improvement and Patient Safety project for Kaleida Health April 2010.
CLIA Waived Testing for Physician Office Labs Doris Thompson, Ph.D., MT (ASCP) AK State Public Health Laboratories State CLIA Program Francisca Lehr, M.S.,
1 1 Chapter 1 Specimen Management Professor A. S. Alhomida Disclaimer The texts, tables and images contained in this course presentation (BCH 376) are.
Virginia Child ID Program and Implementation at Inova Health System
Training Program Version 3.06 Use Page-up and Page-down to scroll through the slide show EZ-Cup Drug Screen The EZ-Cup Drug Screen is only a preliminary.
PREGNANCY TESTING. Signs and symptoms Missed Period Just "Feeling" Pregnant Breast Tenderness Fatigue Frequent Urination Nausea Dizziness Fainting Food.
Adult Transfusion Therapy 2009 Annual Review for RNs and other Transfusionists Annual Review for RNs and other Transfusionists* *“Transfusionist” includes.
Good laboratory practices with waived test systems
This teaching material has been made freely available by the KEMRI-Wellcome Trust (Kilifi, Kenya). You can freely download, adapt, and distribute this.
Kaleida Health Point of Care Glucometer Testing 2011
Exempt Research Mary Banks BS, BSN IRB Director CRC IRB and BUMC IRB.
XceedPro Meter BEDSIDE GLUCOSE The following slides include a review in preparation for completion of the Bedside glucose recert quiz and performance of.
CDRH Review Practice for Over-the-Counter in Vitro Diagnostic Tests
Quality Control Barbara Weberman MT(ASCP) Oakland County Health Division Laboratory Supervisor.
Pregnancy and Ovulation Test Kits Dr. Ed Randell.
10 Rights of Medication Administration
Human chorionic gonadotropin. The hormone human chorionic gonadotropin (better known as hCG) is produced during pregnancy. It is made by cells that form.
Microbiology and Serology
Medication History: Keeping our patients safe. How do we get all of the correct details?
OnSite Rapid Test Procedure Training
For Medical Clinical Staff WellOne Primary Medical and Dental Care Click here to move on.
Module 5 Postanalytical Phase of Laboratory Testing.
Clinitest hCG.
Urine Pregnancy Screening for Research Staff. All Rights Reserved, Duke Medicine 2007 These instructions refer to the QuickVue One-Step hCG Urine test.
GLUCOSE TESTING USING THE TRUEtrack GLUCOMETER
Quickvue In-Line rapid strep a testing
Urine Pregnancy Screening for Research Staff
Recommended by the Sentinel Event Alert Advisory Group NATIONAL PATIENT SAFETY GOALS FY 2009.
1 Accreditation and Certification: Definition  Certification: Procedures by which a third party gives written assurance that a product, process or service.
Pediatric/Adult Transfusion Therapy 2009 Annual Review for RNs and other Transfusionists Annual Review for RNs and other Transfusionists* *“Transfusionist”
Module 5: Assuring the Quality of HIV Rapid Testing
Clinical Skills Observer Training ROLE OF THE CLINICAL SKILLS OBSERVER Evaluate all candidates fairly and objectively.
Module 13: External Quality Assessment (EQA) On-site Evaluation and Re-Testing.
Robert Wood Johnson Medical School HIV Point of Care Testing Program Eugene G. Martin, Ph.D. Evan M. Cadoff, M.D., BLD Associate Professors of Pathology.
EN46001 llc. llc Horizon Medical Technologies' mission is to distribute quality products that are cost effective and unique to the biomedical and healthcare.
This teaching material has been made freely available by the KEMRI-Wellcome Trust (Kilifi, Kenya). You can freely download, adapt, and distribute this.
Introduction to Appointment Scheduling
Session #7: Steps 8-10 Pt provides Urine Sample Performing PT, STD Test sample preparation Reporting PT Results.
1 Module Six: Wrap-Up Screening Information System.
BIM Bridge Inspection and Maintenance Technical Standards Branch Class B Bridge Inspection Course Inspection Policies and Procedures INSPECTION POLICIES.
P1 PRACTICING IQC DAY-TO-DAY Introduction to HIV testing.
Step What happens?. Who is responsible? Procedures needed?
Robert Wood Johnson Medical School HIV Point of Care Testing Program Eugene G. Martin, Ph.D. Evan M. Cadoff, M.D., BLD Associate Professors of Pathology.
Module 8: Blood Collection and Handling Dried Blood Spot
Module 12: Quality Control
RAPID HIV TESTING OraQuick ADVANCE HIV 1/2
Performing HIV Rapid Tests
CHLAMYDIA / GONORRHEA Vaginal Specimen Collection and Form Training NC State Laboratory of Public Health 2015.
Quality Assurance.
Immunochemical Fecal Occult Blood Testing
Freestyle Precision Pro
Field Inventory Services-Sanofi Inventory and Audit Training
Diagnostic Services in Healthcare
iScreen® OFD Cotinine Screen
Quality Control Barbara Weberman MT(ASCP)
Bedside glucose XceedPro Meter
FECAL OCCULT BLOOD TESTING USING SERACULT SLIDES
Bedside glucose XceedPro Meter
GLUCOSE TESTING USING THE TRUEtrack GLUCOMETER
Pregnancy Testing-QuickVue One Step
Presentation transcript:

Nursing and Lab partnering to perform Point of Care testing Nursing and Lab partnering to perform Clearview hCG Combo II

Point of Care Testing (POCT) Recertification Module 2009 Welcome to the 2009 POCT hCG recertification module. In order to become recertified, you must complete the following steps:

hCG levels during pregnancy Human chorionic gonadotropin (hCG) is a glycoprotein hormone produced by the developing placenta shortly after fertilization. In normal pregnancy, hCG can be detected in both urine and serum as early as 7 to 10 days after conception.1-4 hCG levels continue to rise very rapidly, frequently exceeding 100 mIU/mL by the first missed menstrual period, and peaking in the 100,000-200,000 mIU/mL range about 10-12 weeks into pregnancy.2-4 The appearance of hCG in both the urine and serum soon after conception, and its subsequent rapid rise in concentration during early gestational growth, make it an excellent marker for the early detection of pregnancy.

The Kit: Urine hCG testing kit Clearview hCG Combo II Has increased sensitivity, is easy-to-read, and easy-to-use Detects 20 mIU/mL hCG in Urine Can be stored at room temperature CLIA Waived for Urine Only

Intended Use of POCT hCG testing Is performed at locations where it is important to know the pregnancy status of a patient. Is used to determine if a patient can safely undergo a medical procedure It is critically important that the individual performing the test properly: identify the patient, properly identify and label the patient sample and accurately perform and time the test. This kit is approved by Kaleida Health Labs for POCT hCG on urine ONLY.

Prior to Patient Testing Verify your supplies (Clearview hCG COMBO II kit) Each kit contains 40 test devices. Verify the external controls (MAS UA controls) have been run and properly documented for the kit in use, or within 30 days if you are using the same kit for more than 30 days. Check the expiration date on the test device. Do not use expired test devices Test devices should remain in the sealed pouch until used for patient testing or running controls. Open the test device and label the individual device with the patient’s name or alternate unique identifier. Check that sample has been properly labeled Use a timer to time the test. Do not interpret results before 3 minutes or after 5 minutes. Incorrect timing may lead to false negative, false positive or invalid results.

    Documentation   All result information should be appropriately logged on the log sheet unique to each test kit, including Testing Location Kit Lot number Kit Expiration date External controls run once per kit or every 30 days. If you are using the same kit more than 30 days, the external controls must be rechecked and documented every 30 days. Indicate lot number and expiration date of the positive and negative controls. Document results under “external controls” column. Internal controls: refers to the expected results for each test device indicating a valid test. If you observe red lines, document “R” or “Red” in the “internal control” columns indicating the expected results for the internal control were the observed. If test background remains clear, “CL” or “clear” should be documented to indicate the expected testing condition of clear has been observed.

Documentation continued Failure to obtain the expected results: Indicates the test results are invalid and cannot be reported. Invalid results should be repeated. If invalid a second time, send sample to Lab for STAT hCG Only the approved log sheets should be used. When the test kit has been finished, the completed log sheets should be sent to the Lab Patient results should be documented in the chart using the approved test result form (form KH 00659)

Performing HCG testing

Urine hCG test procedure Clearview HCG Combo II Test Procedure                                                                                       Add 3 drops of urine to the Sample Well. ** Note urines exhibiting visible precipitates should be allowed to settle to obtain a clear specimen for testing, filtered, or centrifuged.

Interpreting the Test results Read result in 3 minutes for urine POSITIVE: Two distinct red lines appear. One should be in the control region <C> and the other in the test region <T> NEGATIVE: One red line appears in the control region <C>. No red or pink line appears in the test region <T> INVALID: Control line fails to appear. Causes can be insufficient specimen volume or incorrect procedural technique. Review procedure and repeat with a new test device. If a second invalid is obtained, send sample to Lab for testing. Notify your Nursing Supervisor and discontinue use of the kit and return it to the Laboratory, and notify Laboratory of the problem. Upon completion of the testing the test device should be discarded appropriately.

hCG Testing Point of Care at Kaleida Health All staff designated to perform the testing must be Initially trained by an approved and designated trainer. Re-assessed at 6 months Re-certified annually by completing the re-certification process.

hCG Testing Point of Care at Kaleida Health All testing will be performed: With approved kits according to Kaleida Health Lab Policy LB-POC-06 On patients as ordered by the physician or other licensed healthcare professionals authorized to order testing.

hCG Testing Point of Care at Kaleida Health Results will be completely documented on the appropriate log sheets.

Point of Care hCG Testing is Important Because when done properly it determines the Pregnancy Status of a patient Knowing the pregnancy status of a patient is important information for the caregivers to have accurately and quickly Contributes to improving patient safety as some procedures are not advisable if the patient is pregnant It helps us provide the most efficient and effective care for our patients

The best result comes from using Correct Technique and Specimen Integrity are Critical factors for Accurate Results Just any result is not a good result. Proper procedure and technique must be followed to obtain a good result. The best result comes from using the right kit the correct patient sample, the right procedure, and reporting the right result. Unlabeled samples, improperly performed testing, improper timing of the procedure are some of the contributing factors for a potential “bad” result.

Do the right thing Always take the time to do it right. It really does matter.